Developing Integrated Susceptibility and Conductivity MRI for Next Generation St...
Developing Integrated Susceptibility and Conductivity MRI for Next Generation Structural and Functional Neuroimaging
MRI is indispensable in the diagnosis of neurodegenerative diseases. These are poorly understood while their prevalence and socio-economic burden continue to rise. Structural and functional MRI can provide biomarkers for early dia...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
uImaging
MRI based mapping of microscopic brain composition in a mous...
160K€
Cerrado
MS-fMRI-QSM
Studying Multiple Sclerosis with a novel simultaneous functi...
267K€
Cerrado
SAF2011-29344
EVALUACION DE LA CONECTIVIDAD CEREBRAL USANDO LA TECNICA DE...
73K€
Cerrado
SAF2014-56330-R
EVALUACION DE LA PERFUSION CEREBRAL Y LA CONECTIVIDAD FUNCIO...
91K€
Cerrado
TEC2012-39095-C03-01
BIOMARCADORES BASADOS EN IMAGEN DE RESONANCIA MAGNETICA EN E...
183K€
Cerrado
TEC2009-14587-C03-02
BIOMARCADORES DE NEUROIMAGEN EN ENFERMEDADES NEURODEGENERATI...
70K€
Cerrado
Información proyecto DiSCo MRI SFN
Duración del proyecto: 82 meses
Fecha Inicio: 2018-10-31
Fecha Fin: 2025-09-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
MRI is indispensable in the diagnosis of neurodegenerative diseases. These are poorly understood while their prevalence and socio-economic burden continue to rise. Structural and functional MRI can provide biomarkers for early diagnosis and potential therapeutic intervention. My research vision is to develop novel MRI methods for structural and functional mapping of tissue magnetic susceptibility and electrical conductivity as these show great promise for neuroimaging in diseases such as Alzheimer’s (AD).
Susceptibility mapping (SM), which I pioneered, is uniquely sensitive to tissue composition including iron content affected in AD while conductivity mapping (CM) probably reflects cellular disruption in AD. Resting-state functional MRI (rsfMRI) reveals how AD affects brain networks without any tasks or stimulation equipment. However, each technique currently needs a separate time-consuming MRI scan. I will develop an integrated scan for simultaneous structural SM and CM, and rsfMRI functional connectivity characterisation. This efficient scan, ideal for AD patients, will reveal totally new resting-state networks based on electromagnetic properties: resting-state functional SM and resting-state functional CM for the first time. As changes in blood susceptibility underlie fMRI, rsfSM should measure functional connectivity more directly. This also makes it sensitive to physiological noise so I will develop noise removal methods building on fMRI techniques I established. Initial fSM studies have been at 7 Tesla but I will target the more widespread 3T field to maximise applicability. As a leader in both SM and rsfMRI physiological noise removal I have the ideal background to integrate SM and CM with fMRI and extend them for ground-breaking functional electromagnetic connectivity. This research will yield a rich set of novel, multimodal MRI contrasts to allow development of new combined structural and functional biomarkers for early diagnosis of AD and other diseases.